EUVIMEDEUVIMED entdecken
Crossref

Delayed Percutaneous Coronary Intervention Regulates MMP-9, NOX2, and TGF-β1 After ST-Segment Elevation Myocardial Infarction: A Quasi-Experimental Study

Suryono Suryono, Achmad Ilham Tohari, Muhammad Rijal Fahrudin Hidayat, Muhammad Irsyad Amien, Muhammad Farhan Hibatulloh, Muhammad Naufal Hibatullah, Hazbina Fauqi Ramadhan

Research in Heart Yield and Translational Medicine (RHYTHM) · 2026

DOI: 10.18502/rhythm.v21i3.22564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Heart Yield and Translational Medicine (RHYTHM), 2026. Verfasst von Suryono Suryono und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary percutaneous coronary intervention (PCI) remains the main treatment for patients with ST-segment elevation myocardial infarction (STEMI). Nonetheless, many patients still miss the primary PCI golden period or refuse it, especially in developing countries, such as Indonesia. This study compared the effects of delayed PCI (12–48 hours after STEMI onset) and optimal medical therapy (OMT) on cardiac remodeling biomarkers matrix metalloproteinase-9 (MMP-9), nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2), and transforming growth factor-β1 (TGF-β1).

Methods

This quasi-experimental study enrolled 55 patients with STEMI. Initially, all participants were advised to undergo delayed PCI. Patients who agreed to receive delayed PCI plus OMT were included in group 1 (n=24), and those who refused delayed PCI were included in group 2 and received OMT only. Blood samples were drawn at 24 hours and on day 5 after the intervention. MMP-9, NOX2, and TGF-β1 levels were measured using enzyme-linked immunosorbent assay. Data were analyzed using Stata, version 17.

Results

Group 1 showed significant reductions at 24 hours and day 5 in MMP-9 (Cohen d: −0.97, P

Zitieren

APA

Suryono, S., Tohari, A. I., Hidayat, M. R. F., Amien, M. I., Hibatulloh, M. F., Hibatullah, M. N., & Ramadhan, H. F. (2026). Delayed Percutaneous Coronary Intervention Regulates MMP-9, NOX2, and TGF-β1 After ST-Segment Elevation Myocardial Infarction: A Quasi-Experimental Study. Research in Heart Yield and Translational Medicine (RHYTHM). https://doi.org/10.18502/rhythm.v21i3.22564

Vancouver

Suryono S, Tohari AI, Hidayat MRF, Amien MI, Hibatulloh MF, Hibatullah MN, et al. Delayed Percutaneous Coronary Intervention Regulates MMP-9, NOX2, and TGF-β1 After ST-Segment Elevation Myocardial Infarction: A Quasi-Experimental Study. Research in Heart Yield and Translational Medicine (RHYTHM). 2026. doi:10.18502/rhythm.v21i3.22564

BibTeX
@article{Suryono2026,
  author = {Suryono, Suryono and Tohari, Achmad Ilham and Hidayat, Muhammad Rijal Fahrudin and Amien, Muhammad Irsyad and Hibatulloh, Muhammad Farhan and Hibatullah, Muhammad Naufal and Ramadhan, Hazbina Fauqi},
  title = {Delayed Percutaneous Coronary Intervention Regulates MMP-9, NOX2, and TGF-β1 After ST-Segment Elevation Myocardial Infarction: A Quasi-Experimental Study},
  journal = {Research in Heart Yield and Translational Medicine (RHYTHM)},
  year = {2026},
  doi = {10.18502/rhythm.v21i3.22564}
}
Kostenlos starten →